Swiss Stem Cells Biotech

Executive Summary

Swiss Stem Cells Biotech (SSCB) is a privately held biobank based in Geneva, Switzerland, founded in 2005. The company specializes in the processing and cryopreservation of stem cells derived from umbilical cord blood, cord tissue, placenta, and adipose tissue. SSCB is distinguished as the only private biobank in Switzerland accredited by FACT-NetCord and GMP-certified, positioning it as a leader in stem cell preservation. Its business model encompasses family banking, a public-private hybrid banking model, and contract manufacturing for Advanced Therapy Medicinal Products (ATMPs). With an end-to-end, Switzerland-based operational model, SSCB leverages its regulatory credentials to offer high-quality storage and manufacturing services to both individual families and institutional clients.

Upcoming Catalysts (preview)

• Q3 2026Expansion of ATMP contract manufacturing capabilities70% success
• TBDStrategic partnership with a larger biopharma company for stem cell therapies50% success
• Q4 2026Receipt of additional regulatory certifications (e.g., EMA GMP approval)60% success